Review
doi: 10.1093/ajhp/59.14.1366.
Economic evaluations of olanzapine and risperidone
Affiliations
- PMID: 12132564
- DOI: 10.1093/ajhp/59.14.1366
Item in Clipboard
Review
Economic evaluations of olanzapine and risperidone
Am J Health Syst Pharm.
.
No abstract available
Comment in
-
Olanzapine and risperidone.Am J Health Syst Pharm. 2003 Mar 1;60(5):487-8; author reply 488-9. doi: 10.1093/ajhp/60.5.487. Am J Health Syst Pharm. 2003. PMID: 12635459 No abstract available.
Similar articles
-
Olanzapine and risperidone.Am J Health Syst Pharm. 2003 Mar 1;60(5):487-8; author reply 488-9. doi: 10.1093/ajhp/60.5.487. Am J Health Syst Pharm. 2003. PMID: 12635459 No abstract available.
-
Cost evaluation of risperidone compared with olanzapine.Psychiatr Serv. 2003 May;54(5):742-4. doi: 10.1176/appi.ps.54.5.742. Psychiatr Serv. 2003. PMID: 12719509
-
A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia.Manag Care Interface. 2002 Feb;15(2):75-81. Manag Care Interface. 2002. PMID: 11875967
-
Olanzapine: an updated review of its use in the management of schizophrenia.Drugs. 2001;61(1):111-61. doi: 10.2165/00003495-200161010-00011. Drugs. 2001. PMID: 11217867 Review.
-
Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia.Schizophr Res. 1999 Mar 1;35 Suppl:S101-9. doi: 10.1016/s0920-9964(98)00168-6. Schizophr Res. 1999. PMID: 10190231 Review.
Cited by
-
Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study.Curr Ther Res Clin Exp. 2004 Jan;65(1):57-69. doi: 10.1016/S0011-393X(04)90005-7. Curr Ther Res Clin Exp. 2004. PMID: 24936104 Free PMC article.
-
Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.Drugs. 2007;67(11):1541-66. doi: 10.2165/00003495-200767110-00003. Drugs. 2007. PMID: 17661527 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
